535
edits
Changes
no edit summary
|n/a
|-
|BÜHLMANNQuidel Corp<ref name=”[31]”"Arti21">LF-TLAD25 Quantum Blue® Adalimumab (2018)Quidel QuickVue RIDT Product Information, Quidel, https://www. Leaflet ''LF-TLAD25 Quantum Blue® Adalimumab''quidel. BÜHLMANNcom/sites/default/files/product/documents/EF1350313EN00_1.pdf</ref>|LF-TLAD25QuickVue® Influenza A + B|Yes|Quantum Blue® AdalimumabN\A|10 μL81,5%|1.3 - 35 μg/mL97,8%|1:19NS, NPS, NPA, NPW direct, NP, NPA, NPW in VTM|Intra-assay: CV 1.63*10< 28.6%sup>3<br /sup>Inter-assay: CV 4.4*10<sup>3< 12.6%|15 min/sup>
|}<div style="margin-bottom:1em"><sub>''Table 2: Selection of currently available systems for measuring adalimumab.''<br />*Note: the dilution ratio is defined as 1:x, with x the volume of added reagents relative to the volume of plasma sample</sub></div>